Search by Journal

Neurological Therapeutics

Volume 22, Issue 3 / 2005
English Article   Japanese Article
  • Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
Japanese Article Iatrogenic neurologic disease
Shigeki Kuzuhara
Neurological Therapeutics 22(3): 321-321, 2005.
Japanese Article Endovascular treatment of the stroke
Waro Taki
Neurological Therapeutics 22(3): 322-322, 2005.
Japanese Article Recent progress of the epilepsy practice
辻貞俊
Neurological Therapeutics 22(3): 323-323, 2005.
Japanese Article Ubiquitin proteasome proteolysis system and neuriatria strategy
Ryoho Takahashi
Neurological Therapeutics 22(3): 324-324, 2005.
Japanese Article Opening scene of a play - of the treatment -Brain Attack era of the ischemic cerebrovascular disease
Yoshihiro Kobayashi
Neurological Therapeutics 22(3): 325-325, 2005.
Japanese Article It is clinical condition and treatment of antiMuSK antibody-positive MG myasthenia gravis
Masakatsu Motomura
Neurological Therapeutics 22(3): 326-326, 2005.
Japanese Article Progress of migraine headache treatment
Kenji Nakajima
Neurological Therapeutics 22(3): 327-327, 2005.
Japanese Article It is the prospects of the recent trend and treatment in our country multiple sclerosis
Junichi Kira
Neurological Therapeutics 22(3): 328-328, 2005.
Japanese Article Historic overview of the Botulinum toxin treatment
Takahiro Mesaki
Neurological Therapeutics 22(3): 329-329, 2005.
Japanese Article For neurologic disease patient advocacy for the establishment of action - welfare tutelage support center in Mie -
Narita Yugo
Neurological Therapeutics 22(3): 330-330, 2005.
Japanese Article Ethical social problem in 1 ALS
Mieko Ogino
Neurological Therapeutics 22(3): 331-331, 2005.
Japanese Article Ethic, social problems over 2 dementia practice
Masahiko Saito
Neurological Therapeutics 22(3): 332-332, 2005.
Japanese Article Genetic screening and informed consent in 3 nerves intractable diseases
Takashi Nakajima
Neurological Therapeutics 22(3): 333-333, 2005.
Japanese Article The situation of 4 patients and medical ethic
Shoko Mukai
Neurological Therapeutics 22(3): 334-334, 2005.
Japanese Article Hormone-related treatment of 1 spinal and bulbar atrophy
Origin of Sofue
Neurological Therapeutics 22(3): 335-335, 2005.
Japanese Article 2. Aβ vaecine therapy for Alzheimer's disease
原英夫
Neurological Therapeutics 22(3): 336-336, 2005.
Japanese Article Gene therapy of 3 Parkinson disease
Shinichi Muramatsu
Neurological Therapeutics 22(3): 337-337, 2005.
Japanese Article Examination about the effect of the platinum nano cluster on I-A1-1 rat cerebral hemorrhage model
Hideaki Yoshida, Masashi Kajita, Yusei Miyamoto
Neurological Therapeutics 22(3): 341-341, 2005.
Japanese Article Examination of the microbleed in treatment with antihypertensive agent and the T2* imaging method in I-A1-2 patients with hypertension
Chiaki Arakawa, Haruhiko Hoshino, Tomohide Adachi, A Mizoi law is the best, Maiko Murai, Saori Moriya, Makoto Takagi
Neurological Therapeutics 22(3): 341-341, 2005.
Japanese Article Report of six dural arteriovenous fistula which occurred for cerebral hemorrhage in our I-A1-3 cranial nerve center
Takaaki Fukuchi 1, Kominami historiography 1, Masahiro Mishina 1, Arata Abe 1, Aqueous Takayuki 1, Shiro Kobayashi 1, Tairo Katayama 2
Neurological Therapeutics 22(3): 342-342, 2005.
Japanese Article The hemorrhagic change in the cardiogenic cerebral embolism case given anticoagulant therapy from I-A1-4 acute phase and examination of the on admission ADC level
Kentaro Yamada, Height of Takeshi Yamawaki, Manabu Hattori, Great Kenji Kita, 豊田剛成, 江崎洋江, Takada good luck children, It is praised Shu Nakazawa, Yukio Kojika
Neurological Therapeutics 22(3): 342-342, 2005.
Japanese Article The case that was thought to result in cerebral hemorrhage by I-A1-5 selective serotonin reuptake inhibitor (SSRI)
Masashi Kubo, Yuko Shimizu, Yusuke Tomita, Shinichiro Uchiyama, Makoto Iwata
Neurological Therapeutics 22(3): 343-343, 2005.
Japanese Article Effect on activated platelet of ibudilast in patients with I-A2-1 chronic stage cerebral infarction and platelet agglutinating capacity
Saori Ohara 1, Spring water beauty clothes 2, Masahiro Yamamoto 3, Yasuhisa Kitagawa 4, Shigeji Takagi 1, Yukito Shinohara 5
Neurological Therapeutics 22(3): 343-343, 2005.
Japanese Article Examination about the platelet aggregation suppression of I-A2-2 Losartan and telmisartan
Naoko Yazaki, Hiroshi Yamada, Toshikazu Hirayama, Hiroshi Sugihara, Ritsuko Oikawa, Yoichi Takahashi
Neurological Therapeutics 22(3): 344-344, 2005.
Japanese Article Effect of edarvone on I-A2-3 cardioembolic
Yuichiro Inatomi 1, Toshiro Yonehara 1, Shodo Fujioka 1, Yoichiro Hashimoto 2, Teruyuki Hirano 3, Makoto Uchino 3
Neurological Therapeutics 22(3): 344-344, 2005.
Japanese Article Examination - using the effect on blood pressure and cerebral blood stream volume -24 time heart electric sphygmomanometer and brain SPECT of cilnidipine of the I-A2-5 cerebral infarction chronic stage
Shizuka Sakamoto tree, Arabian bird Tatsuo, Tairo Katayama
Neurological Therapeutics 22(3): 345-345, 2005.
Japanese Article One case of the intracranial hypotension syndrome that healed with the autologous blood patch of I-A3-1 sustained saline injection therapy out of the dura mater and two times
Hiroko Kato, Tetsuro Ando, The Sugiura truth
Neurological Therapeutics 22(3): 345-345, 2005.
Japanese Article One case of the idiopathic intracranial hypotension syndrome that racked its brains about I-A3-2 treatment
Junko Kaneta, Yasushi Kita
Neurological Therapeutics 22(3): 346-346, 2005.
Japanese Article Consult I-A3-3 neurology outpatient; the "dizziness" patients
Jinichi Nunomura
Neurological Therapeutics 22(3): 346-346, 2005.
Japanese Article Examination - of gamma knife treatment - recurrence example for the I-A3-4 intractable trigeminal neuralgia
Shinji Matsuda, Wakako Shirai, Masakazu Onodera, It is the best among a main room back
Neurological Therapeutics 22(3): 347-347, 2005.
Japanese Article Experience of the botulinum toxin treatment for the cervical dystonia with I-A4-1 cerebral infantile palsy
Kosuke Miyake, Hisashi Ito, Yagi Ayaka, Shinya Asayama, Masato Nagashima, 國枝武伸, Satoshi Nakano, Hidefumi Ito, Hirofumi Kusaka, New appearance Akiyo
Neurological Therapeutics 22(3): 347-347, 2005.
Japanese Article Case of the lower limbs dystonia that I-A4-2 Mexiletine was effective
Atsuko Mochizuki, Miki Osawa male, Makoto Iwata
Neurological Therapeutics 22(3): 348-348, 2005.
Japanese Article One case of Restless legs syndrome/Periodic limb movement disorder where I-A4-3 Pramipexole HCl was effective
Kazuo Takahashi, Tetsushi Abe, Kennichi Iijima, Shuhei Yamaguchi, Yoshihiro Kobayashi
Neurological Therapeutics 22(3): 348-348, 2005.
Japanese Article I-A5-1 Levodopa-responsive apraxia of lid opening
Yuko Miyazaki, Ryu Murakami sentence, Shrine stone Masahiro, Katsumi Kurokawa, Yoshihide Sunada
Neurological Therapeutics 22(3): 349-349, 2005.
Japanese Article I-A5-2 larynx trachea isolation postoperative multiple system atrophy case to become able to ingest it, and to talk with an electric larynx
Keiko Adachi 1, Toshiyuki Arima 1, Tatsuya Honda 2, Makoto Uchino 3
Neurological Therapeutics 22(3): 349-349, 2005.
Japanese Article One case of the episodic ataxia that I-A5-3 4-aminopyridine was effective
Kazuhide Miyazaki, Mutsumi Iijima, Shinichiro Uchiyama, Makoto Iwata
Neurological Therapeutics 22(3): 350-350, 2005.
Japanese Article Examination of the long-term effect of taltirelin hydrate for hereditary cerebellar ataxia to chain I-A5-4 chromosome 16
Ryuichi Okubo, 有里敬代, 有村公良, Mitsuhiro Osame
Neurological Therapeutics 22(3): 350-350, 2005.
Japanese Article Examination of the musculus dilatator pupillae dysfunction in I-B1-1 Parkinson disease
Kentaro Yamakawa, Hideyuki Sawada, 下濱俊, Ryoho Takahashi
Neurological Therapeutics 22(3): 351-351, 2005.
Japanese Article Integrity incontinence-like psychiatric symptoms found in Parkinson disease /Parkinson syndrome of the I-B1-2 youth onset
Keiko Mizobuchi, Fujinuma Yoshikatsu, Hayakawa province, 宗像紳, Shigeyuki Kojima
Neurological Therapeutics 22(3): 351-351, 2005.
Japanese Article Treatment of denaturing type parkinsonism with the I-B1-3 kubisagari posture
Yasushi Kita
Neurological Therapeutics 22(3): 352-352, 2005.
Japanese Article Examination of the utility of polycarbophil calcium for the constipation symptom of patients with I-B1-4 Parkinson disease
Taro Yamashita 1, Yuki Ando male 2, Mitsuharu Ueda 1, 岡本定久 1, Makoto Uchino 1
Neurological Therapeutics 22(3): 352-352, 2005.
Japanese Article Two cases of Parkinson disease that had a relapse of an I-B2-1 sigmoid colon axis rotation symptom
Goto land tax officer 1, Hidenori Matsuo 1, Matsuya silk tree 1, Takamitsu Mizota 1, Shinji Hamazaki 1, Small Satoshi Torii 2, 福留隆泰 1, Takayuki Kondo 2, 澁谷統寿 1
Neurological Therapeutics 22(3): 353-353, 2005.
Japanese Article Effect of the lower limbs truncal muscle strengthening exercise on highly easy fall characteristics of I-B2-2 Parkinson disease
Keiji Senda 1, Tatsuya Nakamura 1, 神一敬 1, Norio Abe 1, Hironobu Fujita 2, Ryo Misawa 2
Neurological Therapeutics 22(3): 353-353, 2005.
Japanese Article Effect - UPDRS of the music therapy for I-B2-3 Parkinson disease and examination - of the effect to give to blood pressure
Yuko Hattori, Tatsuya Hattori
Neurological Therapeutics 22(3): 354-354, 2005.
Japanese Article The present conditions in this hospital of the deep part basal ganglia stimulation therapy for I-B3-1 Parkinson disease
豊田剛成 1, Kentaro Yamada 1, Great Kenji Kita 1, Shu Nakazawa 1 to praise, Height of Takeshi Yamawaki 1, Yukio Kojika 1, Jun Umemura 2, Mizuguchi Maria 3
Neurological Therapeutics 22(3): 354-354, 2005.
Japanese Article Neuropsychological change by the bilateral subthalamic nucleus stimulation technique for I-B3-2 Parkinson disease
Reiko Fukatsu 1, Takashi Oikawa period 1, History of Hajime Ando 2, Kernel village Taro 3, Kinnya Hisanaga 1, Masaaki Kato 1, Hiroshi Saito 1
Neurological Therapeutics 22(3): 355-355, 2005.
Japanese Article Examination of the subthalamic nucleus stimulation using the I-B3-3 cerebral blood flow SPECT
Sako just one 1, Chiharu Tanaka 1, Masahiro Mizobuchi 1, Atsuko Nihei 1, Masami Takanashi 2
Neurological Therapeutics 22(3): 355-355, 2005.
Japanese Article About the change of orexin concentrations out of the cerebrospinal fluid by I-B3-4 subthalamic nucleus deep part stimulation technique (STN-DBS)
Hiroshi Asai British 1, Yoshiko Furuya 1, Satoshi Ueno 1, Hidehiro Hirabayashi 2, 榊壽右 2, Takashi Kanbayashi 3, Tetsuo Shimizu 3, 宇高不可思 4
Neurological Therapeutics 22(3): 356-356, 2005.
Japanese Article Search of surrogate marker in the I-B4-1 spinal and bulbar atrophy
Haruhiko Sakano, 勝野雅央, Hiroaki Adachi, Waza Masahiro, Makoto Minamiyama, Naoki Atsuta, 渡邉宏久, Akira Tanaka view, 道勇学, Origin of Sofue
Neurological Therapeutics 22(3): 356-356, 2005.
Japanese Article Analysis of the effect of treatment with the LH-RH agonist in patients with I-B4-2 spinal and bulbar atrophy
山本知孝 1, Yoshikazu Ugawa 1, Goto order 1, Naoyuki Miyake 2, Shoji Tsuji 1
Neurological Therapeutics 22(3): 357-357, 2005.
Japanese Article methylcobalamin high dose therapy for the I-B4-3 spinal and bulbar atrophy
Keiko Azuma 1, Ryuichi Okubo 1, 有村公良 1, Mitsuhiro Osame 1, Nakagawa teachings of Buddha 2
Neurological Therapeutics 22(3): 357-357, 2005.
Japanese Article Trial of the intramedullary bone marrow transplantation in the I-B5-1 ALS model mouse
Shizuka Onishi straight 1, Hidefumi Ito 1, Sum hand Reika 1, 張建華 1, Satoshi Nakano 1, Hirofumi Kusaka 1, Yasuhiro Suzuki 2, Susumu Ikehara 2, Yasushi Adachi 3
Neurological Therapeutics 22(3): 358-358, 2005.
Japanese Article Gene therapy of the familial amyotrophic lateral sclerosis using I-B5-2 siRNA
Takanori Yokota, Yuki Saito, 水澤英洋
Neurological Therapeutics 22(3): 358-358, 2005.
Japanese Article Cervical spondylotic myelopathy as the risk factor of the I-B5-3 ALS
Tomohiko Ishihara, Shuichi Igarashi, Keiko Tanaka, Masatoyo Nishizawa
Neurological Therapeutics 22(3): 359-359, 2005.
Japanese Article Examination of the factor about prognosis of the I-B6-1 multiple system atrophy
Motoko Sakai, Masaaki Konagaya, 久留聡
Neurological Therapeutics 22(3): 359-359, 2005.
Japanese Article It is the relation with the L-DOPA dose cervical dystonia found in I-B6-2 MSA
Mayu Kizawa period, Haruki Koike, 渡辺宏久, Masaaki Hirayama, Origin of Sofue
Neurological Therapeutics 22(3): 360-360, 2005.
Japanese Article Needle electromyogram findings, nerve conduction velocity findings in the I-B6-3 multiple system atrophy
Hideki Sato, Norihiro Suzuki
Neurological Therapeutics 22(3): 360-360, 2005.
Japanese Article One case that acetazolamide is effective for an advanced cerebellum symptom into I-B6-4 stairs form
駒井清暢 1, Seiji Yamada 1, Hidehiro Yokochi 2, Masaharu Takamori 3
Neurological Therapeutics 22(3): 361-361, 2005.
Japanese Article A survival benefit of the intermittent respirator therapy for I-B7-1 Duchenne muscular dystrophy and the change of the cause of death
Masaaki Konagaya 1, Motoko Sakai 1, 久留聡 1, Seigo Kimura 1, Fumihiko Yasuma 2
Neurological Therapeutics 22(3): 361-361, 2005.
Japanese Article Clinical analysis of 12 I-B7-2 myotonic dystrophy tracheotomy patients
久留聡, Masaaki Konagaya, Motoko Sakai
Neurological Therapeutics 22(3): 362-362, 2005.
Japanese Article Disorder muscle distribution and skeletal muscle MRI of I-B7-3 myotonic dystrophy
村田顕也 1, High group Miwa 2, 斉木臣二 1, Saiki three bell 1, Toshi Kataoka 1, Koichiro Sakai 1, Hirose source Jiro 1
Neurological Therapeutics 22(3): 362-362, 2005.
Japanese Article Effect of the immunological treatment on I-B7-4 Dysferlinopathy case
Toshiaki Takahashi 1, Masashi Aoki 2, Vertical mountain Maki 2, Takafumi Hasegawa 2, Yutaka Shiga original 2, Hiroshi Saito 3, Hidehiko Konno 1, Itaru Kimura 1, Yasuto Itoyama 2
Neurological Therapeutics 22(3): 363-363, 2005.
Japanese Article One case of the polymyositis who had the I-B8-1 thrombotic thrombocytopenic purpura
Shigeko Ogura, Yutaka Koga, Toshihiko Ozeki, Nogura just one, Hiroko Yamamoto
Neurological Therapeutics 22(3): 363-363, 2005.
Japanese Article About a regimen of the polymyositis against I-B8-2 steroid therapy
Masaru Aoki tree, Tatsuya Sato, Akihiro Fujii
Neurological Therapeutics 22(3): 364-364, 2005.
Japanese Article Episode of care of six inclusion body myositis receiving the I-B8-3 high-dose intravenous immunoglobulin
Hiroyuki Ishiura 1, 三方崇嗣 1, 山本知孝 1, Goto order 1, Jun Shimizu 1, Shoji Tsuji 1, Naoyuki Miyake 2
Neurological Therapeutics 22(3): 364-364, 2005.
Japanese Article One case of senile depression that produced SIADH and malignant syndrome by I-C1-1 selective serotonin reuptake inhibitor (SSRI)
Yutaka Koga, 矢野成昭, 三原貴照, Nogura just one, Hiroko Yamamoto
Neurological Therapeutics 22(3): 365-365, 2005.
Japanese Article I-C1-2. Association between "depression" expression and EEG changes in interferon(IFN)-α therapy in chronic hepatitis C (CH)
亀井聡1, 水谷智彦1, 田中直英2, 荒川泰行2, 小島卓也3
Neurological Therapeutics 22(3): 365-365, 2005.
Japanese Article Selenium chromium deficiency that developed in patients with Crohn's disease during total parenteral nutrition enforcement for I-C1-3 long term
森麗, Sei Watanabe tree, Teruyuki Hirano, Daijiro Ishihara, Hiroyuki Omori, Taro Yamashita, Makoto Uchino
Neurological Therapeutics 22(3): 366-366, 2005.
Japanese Article Trial of the dichloroacetate therapy for I-C1-4 MELAS
廣谷真 1, Shinsuke Hamada 1, Miyazaki male straight 1, 岸本利一郎 1, Akihiko Ogata 1, Seishi Kikuchi 1, Hidenao Sasaki 1, Yasushi Mito period 2, Kazuto Yoshida 2
Neurological Therapeutics 22(3): 366-366, 2005.
Japanese Article I-C2-1. For clinical significance of α-galactosidase A activity mild decline example
吉澤利弘, 新里寿美子, 古庄健太郎, 庄司進一
Neurological Therapeutics 22(3): 367-367, 2005.
Japanese Article The risk of the glycerol administration in cerebral oedema of the I-C2-2 adult type citrullinemia (CTLN2) patients
Masahide Yazaki 1, Yoichi Takei 1, Shuichi Ikeda 1, Keiko Kobayashi 2, Takeyori Saeki 2
Neurological Therapeutics 22(3): 367-367, 2005.
Japanese Article Two cases of cerebellar cortex atrophy with I-C2-3 Hashimoto's disease
Ichiro Yabe 1, Tetsuro Yanagihara 2, Hidenao Sasaki 1
Neurological Therapeutics 22(3): 368-368, 2005.
Japanese Article Examination of the interferon therapy in patients with multiple sclerosis to repeat frequent recurrence remission in the I-C3-1 this hospital
Kazuo Takada, The Nishigo sum truth, Shoichi Miyamoto, Yoshinobu Mitsui, 楠進
Neurological Therapeutics 22(3): 368-368, 2005.
Japanese Article I-C3-2. Treatment evaluation of IFN-β1b against multiple sclerosis: Comparison of the clinical background of responder and non-responder
中嶋秀人, 細川隆史, 佐藤智彦, 藤村智恵子, 石田志門, 古玉大介, 杉野正一, 木村文治, 花房俊昭
Neurological Therapeutics 22(3): 369-369, 2005.
Japanese Article I-C3-3. The effect of neutralizing antibodies to interferon-β-1b in patients with multiple sclerosis
田中耕太郎, 久住呂友紀, 鈴木重明, 鈴木則宏
Neurological Therapeutics 22(3): 369-369, 2005.
Japanese Article I-C4-1 Relapse prevention of multiple sclerosis by phosphodiesterase inhibitors : Experience in our department
佐藤勝, 自見隆弘, 原一, 村橋真, 今川篤子, 若山吉弘
Neurological Therapeutics 22(3): 370-370, 2005.
Japanese Article One case of the opticospinal multiple sclerosis with the hypothalamic lesion which responded to I-C4-2 plasma exchange
Watanabe pax 1, Ichiro Nakajima 1, Kazuo Fujiwara 1, Miyazawa Isabel 1, Misu Kenro 1, Yutaka Shiga original 1, Yasuto Itoyama 1, Yoichi Nakagawa 2
Neurological Therapeutics 22(3): 370-370, 2005.
Japanese Article One case of the multiple sclerosis that resulted in agammaglobulinemia by I-C4-3 Carbamazepine
Yuji Tanaka, Akira Kimura husband, 保住功, Takashi Inuzuka
Neurological Therapeutics 22(3): 371-371, 2005.
Japanese Article I-C4-4. One cases of multiple sclerosis, which exhibited a migraine attack while using the interferon-β-1b
吉田一人, 水戸泰紀, 佐藤和則, 廣谷真
Neurological Therapeutics 22(3): 371-371, 2005.
Japanese Article A diagnosis and treatment in the I-C5-1 intravascular malignant lymphomatosis (IML) case which we diagnosed during the lifetime
Masashi Tsujimoto, Saori Morozumi, Keizo Yasui, Yasuhiro Hasegawa, 柳務
Neurological Therapeutics 22(3): 372-372, 2005.
Japanese Article The childhood traumatic spinal cord injury that presented an abnormal signal in the spinal cord center where I-C5-2 steroid-pulse therapy was effective
Kiyomi Nanun, Mitsuru Kawamura, Hieda Sotaro, Hideki Ono, Hidetomo Murakami
Neurological Therapeutics 22(3): 372-372, 2005.
Japanese Article Effect of the treatment with mirror using sight feedback for the phantom pain after the I-C5-3 right upper extremity amputation
Akira Shindo University 1, 宮崎眞佐男 2, Masato Matsuyama 2
Neurological Therapeutics 22(3): 373-373, 2005.
Japanese Article Dopamine therapy in I-C6-1 motor aphasia
山崎正禎 1, 宮崎眞佐男 2, Masato Matsuyama 2, Taku Nishida 2
Neurological Therapeutics 22(3): 373-373, 2005.
Japanese Article Acetylcholine therapy in I-C6-2 sensory aphasia
Yuka Machino, 宮崎眞佐男, Masato Matsuyama, Taku Nishida
Neurological Therapeutics 22(3): 374-374, 2005.
Japanese Article The clinical manifestations of 11 I-C6-3 idiopathic normal pressure hydrocephalus and course
Yoko Nakano
Neurological Therapeutics 22(3): 374-374, 2005.
Japanese Article Examination of orexin concentrations out of the cerebrospinal fluid in a lot of I-C6-4 neurologic disease
Mayumi Senda 1, Nogura just one 1, Hiroko Yamamoto 1, Takashi Kanbayashi 2, Tetsuo Shimizu 2
Neurological Therapeutics 22(3): 375-375, 2005.
Japanese Article One case of the cryptococcal meningoencephalitis that showed significant high level of the I-C7-1 cryptococcus antigen dilution titer
Yukio Fujita, Koichi Okamoto
Neurological Therapeutics 22(3): 375-375, 2005.
Japanese Article The brain aspergillus symptom which presented I-C7-2 orbital apex syndrome
Shinsuke Hamada 1, 加納崇裕 1, Kazunori Sato 1, 岸本利一郎 1, Field size 4, Ichiro Yabe 1, Akihiko Ogata 1, Seishi Kikuchi 1, Yutaka Sawamura 2, Tomoo Ito 3, Hidenao Sasaki 1
Neurological Therapeutics 22(3): 376-376, 2005.
Japanese Article Remedial examination of the I-C7-3 cryptococcus brain, meningitis 4 case
Saori Morozumi, Masashi Tsujimoto, Keizo Yasui, Yasuhiro Hasegawa, 柳務
Neurological Therapeutics 22(3): 376-376, 2005.
Japanese Article The fosfluconazole administration method for the cryptococcus meningitis recommended from drug concentration out of the I-C7-4 cerebrospinal fluid
木村活生, Yasushi Baba still, 遠藤雅直, Takehiko Nishiyama, Suzuki dream, Yoshiyuki Kuroiwa
Neurological Therapeutics 22(3): 377-377, 2005.
Japanese Article About a steroid utility in the I-C8-1 tuberculous ulcer hypertrophic cranial pachymeningitis
Atsushi Kuga, 宇羽野恵, Yoshikazu Uesaka, Country book Masaya
Neurological Therapeutics 22(3): 377-377, 2005.
Japanese Article One case of the hypertrophic dura mater flame due to maxillary sinusitis that repeated I-C8-2 TIA-like symptom
Anti-head Yuichiro, Flat Masanori Ide, Emiko Ota, Shindo Yorimasa, Shiozawa Masaji
Neurological Therapeutics 22(3): 378-378, 2005.
Japanese Article One case of the rheumatic hypertrophic cranial pachymeningitis that hoarseness and dysphagia due to I-C8-3 both sides tongue throat, vagus nerve disorders restored by a steroid chronic administration
Yuichiro Ii, Shigeki Kuzuhara
Neurological Therapeutics 22(3): 378-378, 2005.
Japanese Article One case of the Spontaneous cerebrospinal fluid rhinorrhea pregnant woman who I-C8-4 pneumocephalus and meningitis were treated conservatively, and was available for natural childbirth
Yasuhiro Ito, 近藤直英, Yoshiro Ando, Takeshi Yasuda
Neurological Therapeutics 22(3): 379-379, 2005.
Japanese Article Allogeneic marrow stem cell transplantation in the I-D1-1 Crow-Fukase syndrome
有村公良
Neurological Therapeutics 22(3): 380-380, 2005.
Japanese Article Change of the blood purification therapy - serum VEGF level in the I-D1-2 Crow-Fukase syndrome and clinical symptom -
王子聡, Takao Mitsui, Aya Okuma, Misato Takahama, Manabu Onuki, Kyoichi Nomura
Neurological Therapeutics 22(3): 380-380, 2005.
Japanese Article I-D1-3 antiMAG antibody-related neuropathic clinical analysis
吉田拓弘, Gono Takahisa, Masahide Yazaki, Masayuki Matsuda, Shuichi Ikeda
Neurological Therapeutics 22(3): 381-381, 2005.
Japanese Article Neuropathic clinical form and treatment response with the I-D1-4 Sjogren syndrome
Keiko Mori, 1, Yamadashin, Masahiro Iijima, Haruki Koike, Naoki Hattori, Origin of Sofue
Neurological Therapeutics 22(3): 381-381, 2005.
Japanese Article One case thought to be the subtype of I-D2-1 IVIg and CIDP which significant muscle of upper extremity abnormal findings in the MRI improved by steroid therapy
Shunji Yazaki, 白石眞, Masahiro Horiuchi, Yoichi Takahashi
Neurological Therapeutics 22(3): 382-382, 2005.
Japanese Article Efficacy of the immunoglobulin high dose therapy for I-D2-2 Diabetic polyradiculopathy
Katsumi Kurokawa, Saori Hayashi, Ryu Murakami sentence, Yoshihide Sunada
Neurological Therapeutics 22(3): 382-382, 2005.
Japanese Article Radial nerve palsy that was treated effectively with intravenous immune globulin therapy with I-D2-3 Type I diabetes mellitus
Megumi Takeuchi 1, 赫洋美 1, Makoto Iwata 1, Toyokazu Saito 2
Neurological Therapeutics 22(3): 383-383, 2005.
Japanese Article Paraneoplasic sensory neuropathic one case that repeated I-D2-4 gamma globulin large quantities intravenous-injection treatment (IVIg)
Hiroshi Ueshima order 1, Hisashi Ito 1, Maiko Higuchi 1, 武尾真宏 1, Kosuke Miyake 1, Yagi Ayaka 1, Satoshi Nakano 2, Hidefumi Ito 1, Hirofumi Kusaka 1, Junichi Morita 1
Neurological Therapeutics 22(3): 383-383, 2005.
Japanese Article One case of radiation neuropathy which occurred by the radiotherapy to I-D3-1 breast cancer metastases in the 14th year
Azuma Irie I, 若山幸示, Jin Suzuki, 清水夏繪, Seiichi Ono
Neurological Therapeutics 22(3): 384-384, 2005.
Japanese Article Case of the SGPG neuropathy that repeated an ankle sprain from I-D3-2 40 generations, and led to lower limbs bathyesthesia severe disability for women
Hiroyuki Omori, Sei Watanabe tree, Taro Yamashita, Makoto Uchino
Neurological Therapeutics 22(3): 384-384, 2005.
Japanese Article Efficacy of the internal use treatment for spontaneous dysesthesia in the I-D3-3 carpal tunnel syndrome
Masahide Kondo 1, Yosuke Kawana 1, Yutaka Naito 2, Shigeki Kuzuhara 2
Neurological Therapeutics 22(3): 385-385, 2005.
Japanese Article Utility of the artificial anus for patients with familial amyloid polyneuropathy that quality of life decreased because of I-D3-4 faecal incontinence remarkably
Yukiko Okubo, 保月隆良, Michio Nonaka, Imai wealth, Susumu Chiba, Hiroyuki Matsumoto
Neurological Therapeutics 22(3): 385-385, 2005.
Japanese Article Examination of II-A1-1 Chronic post-non-bacterial infection headache(CPIH)
Yasushi Takase, Jin Kishigami, Misa Nakano, Chika Tatsumi husband
Neurological Therapeutics 22(3): 386-386, 2005.
Japanese Article It is protective efficacy (2) of atorvastatin in the case without the headache only by II-A1-2 typical harbinger
Hamamoto truth 1, Tairo Katayama 2
Neurological Therapeutics 22(3): 386-386, 2005.
Japanese Article Examination of the triptan in the II-A1-3 Tottori University cranial nerve internal medicine headache outpatient department
Bunch cheap Emi, Takeshima Taga husband, Haruko Araki, Tamami Ijiri, Prince Ishizaki Ikuko, Kenji Nakajima
Neurological Therapeutics 22(3): 387-387, 2005.
Japanese Article Two cases of the ergotamine abuse headache that came by drug secession by II-A1-4 inpatient care
Yukiko Nomura, Kiyoshi Negoro, Yukiko Tada, Junichi Ogasawara, Kawai former fine weather, Takashi Kanda
Neurological Therapeutics 22(3): 387-387, 2005.
Japanese Article 36 years old man case of the migraine hemiplegic that the family history that the attack that II-A2-1 is frequent responded to verapamil is not clear
清水文崇, 佐野泰照, Junichi Ogasawara, Kawai former fine weather, Kiyoshi Negoro, Takashi Kanda
Neurological Therapeutics 22(3): 388-388, 2005.
Japanese Article Two cases of the migraine headache that showed epileptic electric discharge for II-A2-2 electroencephalogram
Mitsuhiko Yamano 1, Naoki Akamatsu 1, 辻貞俊 1, Masayuki 2 who resigns from the post
Neurological Therapeutics 22(3): 388-388, 2005.
Japanese Article Fact-finding - by problems - questionnaire for II-A2-3 chronic headache practice improvement
Shintaro Yui, Yukiko Ujiie, Fumihiko Sakai
Neurological Therapeutics 22(3): 389-389, 2005.
Japanese Article An effect and side effect of the II-A2-4 Rizatriptan orally disintegrating tablet
Hisashi Igarashi Kei 1, 2, Fumihiko Sakai 2
Neurological Therapeutics 22(3): 389-389, 2005.
Japanese Article One case of the stiff-person syndrome treated effectively with II-A3-1 thymomectomy and intravenous immune globulin therapy
Upper Hara flat 1, Hiroyuki Murai 1, Hitoshi Kikuchi 1, 谷脇考恭 1, Junichi Kira 1, Yoshio Tsuboi 2
Neurological Therapeutics 22(3): 390-390, 2005.
Japanese Article Surgical cure of the II-A3-2 intractable head posttraumatic epilepsy
Naoki Akamatsu 1, Mitsuhiko Yamano 1, 辻貞俊 1, Ei Urasaki Ichiro 2
Neurological Therapeutics 22(3): 390-390, 2005.
Japanese Article II-A3-3. Sustainability partial epilepsy of autoantibody-positive against NMDA glutamate receptor subunit ε2 (Video Kyoran)
黒原和博1, 黒田康夫1, 高橋幸利2
Neurological Therapeutics 22(3): 391-391, 2005.
Japanese Article Transluminal medication - not to smash II-A3-4 simple suspension method - tablet
Is Kurata; see it; 1, Atsuko Imagawa 2, Masaru Sato 2, Original one 2, Yoshihiro Wakayama 2
Neurological Therapeutics 22(3): 391-391, 2005.
Japanese Article Effect of treatment of paroxetine for the depression symptom of II-A4-1 Parkinson disease
Seiichi Kawabe, Kiyoko Hirano, Osamu Igarashi, 青柳丞, 清塚鉄人, 岩本康之介, Hiroaki Iguchi, Toshiki Fujioka, Yasuo Iwasaki
Neurological Therapeutics 22(3): 392-392, 2005.
Japanese Article One case (video demonstration) of Wilson's disease improved by II-A4-2 treatment remarkably
Tool Shinko, Takashima Shutaro, Etsuko Sasahara, Yoshiharu Taguchi, Hiroshi Inoue
Neurological Therapeutics 22(3): 392-392, 2005.
Japanese Article The music therapy using the II-A4-3 song improves Parkinson walk
Masayuki Sato 1, Katsuhiko Takeda 2, Shigeki Kuzuhara 1
Neurological Therapeutics 22(3): 393-393, 2005.
Japanese Article One case of the severe spinal cord type multiple sclerosis that immunoglobulin large quantities intravenous-injection treatment was effective for II-B1-1 acute phase
Jin Abe period 1, Yoshihiro Tanno 1, Tetsuya Ishihara 1, Jin Kubo 1, Naoki Izawa 1, Soichi Katayama 1, Teiji Yamamoto 2
Neurological Therapeutics 22(3): 394-394, 2005.
Japanese Article Treatment with II-B1-2 onset, adrenocorticosteroid for the cerebrum lesion repeating loss and vitamin B6
Masato Tamura, Akira Shinpo, Hiroshi Shiota, Kenji Miki, Katsuhiko Ogawa, Ryuta Kawanishi, Toshiaki Takasu
Neurological Therapeutics 22(3): 394-394, 2005.
Japanese Article One case of the acute disseminated encephalomyelitis that became the anaphylatic shock during II-B1-3 steroid-pulse therapy
Naoki Onodera 1, Masahiko Inoue 2, Yoshihiro Wakayama 2, Yuzuru Kawase 3
Neurological Therapeutics 22(3): 395-395, 2005.
Japanese Article Two cases of the myelitis with the atopic predisposition that showed II-B1-4 steroid therapy resistance
Sakajiri Kenichi 1, Yoshihisa Ikeda 1, History of Yoshinaga intellect 1, Shinji Uchiyama 1, 駒井清暢 2
Neurological Therapeutics 22(3): 395-395, 2005.
Japanese Article It is importance of the preventive medicine the clinical radiologic characteristic of II-B2-1 Megadolichobasilar artery six
Ken Ikeda 1, Wada incense 1, Yasuo Iwasaki 2
Neurological Therapeutics 22(3): 396-396, 2005.
Japanese Article edaravone combination and infection merger frequency of the II-B2-2 cerebral infarction acute phase
Yasushi Daimon Kotobuki, 竹川英宏, Kunihiko Sakurai, Akinori Hozumi, 横田徳継, Koichi Hirata
Neurological Therapeutics 22(3): 396-396, 2005.
Japanese Article One case of II-B2-3 Reversible posterior leukoencephalopathy syndrome
Yoshihiro Tanno 1, Jin Abe period 1, Chikako Watanabe 1, Jin Kubo 1, Naoki Izawa 1, Tetsuya Ishihara 1, Soichi Katayama 1, Teiji Yamamoto 2
Neurological Therapeutics 22(3): 397-397, 2005.
Japanese Article Merger of the superior mesenteric artery syndrome in the II-B2-4 neurologic disease long-term contraction of a disease patients
Masaya Oda, 宇高不可思, Kazuto Nishinaka, Akiko Tamura, Hideaki Matsui, 久堀保, Masakuni Kameyama
Neurological Therapeutics 22(3): 397-397, 2005.
Japanese Article About an effect of the donepezil HCl on II-B3-1 vascular dementia
Osamu Igarashi, 青柳丞, Kiyoko Hirano, 岩本康之介, 清塚鉄人, Seiichi Kawabe, Hiroaki Iguchi, Toshiki Fujioka, Yasuo Iwasaki
Neurological Therapeutics 22(3): 398-398, 2005.
Japanese Article About an effect of the amantadine HCl on II-B3-2 vascular dementia
青柳丞, Hiroaki Iguchi, Seiichi Kawabe, Osamu Igarashi, 清塚鉄人, 岩本康之介, Kiyoko Hirano, Yoshiaki Iwasa, Toshiki Fujioka, Yasuo Iwasaki
Neurological Therapeutics 22(3): 398-398, 2005.
Japanese Article Change of FDG-PET findings before and after the donepezil HCl administration in II-B3-3 Lewy corpuscle type dementia
Masahiko Suzuki 1, Masaya Hashimoto 1, Tadashi Kurita 1, Kenji Ishii 2, Toshiaki Hirai 1, Kiyoharu Inoue 1
Neurological Therapeutics 22(3): 399-399, 2005.
Japanese Article Effect of the donepezil HCl on cerebral blood stream volume of patients with II-B3-4 Alzheimer disease
Yutaka Suzuki, Tomohiko Mizutani
Neurological Therapeutics 22(3): 399-399, 2005.
Japanese Article From the experience in examination - Kunitachi West Niigata center hospital about the case that was hospitalized as II-B4-1 ALS, and a diagnosis was changed to subsequently for 9 years -
Masami Tanaka 1, Prince Kikukawa period 1, Atsushi Mano 1, Kotaro Endo 1, Lower field glory 1, Takashi Suzuki 1, Keiko Tanaka 2
Neurological Therapeutics 22(3): 400-400, 2005.
Japanese Article Case study - in noninvasive positive pressure ventilation therapy - this hospital in II-B4-2 amyotrophic lateral sclerosis
Kawamata Chizuru, Mitsuya Morita, Imaharu Nakano
Neurological Therapeutics 22(3): 400-400, 2005.
Japanese Article II-B4-3 Usefulness of cough machine, percussionaire in ALS
矢野貴久子, 荻野美恵子, 荻野裕, 飯ヶ谷美峰, 坂井文彦
Neurological Therapeutics 22(3): 401-401, 2005.
Japanese Article II-B5-1 antiMuSK antibody negative, histories of treatment of systemic type Sero-negative myasthenia gravis
Shingo Konno, 野本信篤, Hiroshi Nemoto, Norio Wakata, Teruyuki Kurihara
Neurological Therapeutics 22(3): 401-401, 2005.
Japanese Article II-B5-2 antiAChR antibody negative, immunoglobulin large quantities intravenous-injection treatment for the antiMuSK antibody-positive myasthenia gravis intractable case
Hirokazu Takahashi 1, Naoki Kawaguchi 1, Yuko Nemoto 2, Kodo Hattori 1
Neurological Therapeutics 22(3): 402-402, 2005.
Japanese Article One case of Lambert-Eaton myasthenic syndrome that showed neurologic symptoms and the improvement of electromyogram findings by II-B5-3 3, 4-diaminopyridine internal use
Kazuhiro Endo, Nozomi Matsuda, Teiji Yamamoto
Neurological Therapeutics 22(3): 402-402, 2005.
Japanese Article One case of nonneoplastic Lambent-Eaton Myasthenic Syndrome(LEMS) where II-B5-4 Prednisolone and 3, 4-diaminopyridine were effective
Kazunori Sato 1, Yasushi Mito period 1, Kazuto Yoshida 1, 岸本利一郎 2, Miyazaki male straight 2, Ichiro Yabe 2, Akihiko Ogata 2, Seishi Kikuchi 2, Hidenao Sasaki 2, Masakatsu Motomura 3
Neurological Therapeutics 22(3): 403-403, 2005.
Japanese Article Examination - of -21 effects of zonisamide in II-B6-1 Parkinson disease
Hideaki Harada
Neurological Therapeutics 22(3): 403-403, 2005.
Japanese Article Effect of the selegiline HCl supplementation on II-B6-2 early Parkinson disease
Saza tree and rock male 1, 塚口眞砂 1, Kazushi Deguchi 1, Tetsuo Toge 2, Hiroaki Takeuchi 3
Neurological Therapeutics 22(3): 404-404, 2005.
Japanese Article pramipexole treatment for II-B6-3 Parkinson disease
Eiji Mizuta
Neurological Therapeutics 22(3): 404-404, 2005.
Japanese Article Case of the progressive supranuclear palsy that II-B6-4 Pramipexole HCl was effective
Naoyuki Kitagawa 1, Eiji Mizuta 1, Teiko Kuno 2
Neurological Therapeutics 22(3): 405-405, 2005.
Japanese Article Examination about the direct change of the dopamine agonist in patients with II-B7-1 advanced Parkinson disease
Kunihiko Sakurai, Akinori Hozumi, Yoshiaki Kaji, Hideaki Tanaka, Koichi Hirata
Neurological Therapeutics 22(3): 405-405, 2005.
Japanese Article The effect that II-B7-2 Pergolide mesilate gives to striatum metallothionein instruction and lipid peroxide production
Shinichi Ono 1, 2, Eiichi Tokuda 1, Koichi Hirai 1, Takashi Suzuki 1
Neurological Therapeutics 22(3): 406-406, 2005.
Japanese Article Judgment of the Parkinson disease effect of treatment by zonisamide using the II-B7-3 life coder
Noboru Nakahara will tree 1, Akiko Watanabe 1, Tadashi Saito 2, Kazuhiro Endo 1, Teiji Yamamoto 1
Neurological Therapeutics 22(3): 406-406, 2005.
Japanese Article Histories of treatment of six II-Cl-1 axiality dystonia
Hisashi Ito 1, Junichi Morita 2, Kengo Fujita 3, Satoshi Nakano 1, Hidefumi Ito 1, Hirofumi Kusaka 1
Neurological Therapeutics 22(3): 407-407, 2005.
Japanese Article Examination - by the effect of the depressive state -botulinum toxin therapy in the II-C1-2 spasmodic torticollis
Miki Osawa male, Makoto Iwata
Neurological Therapeutics 22(3): 407-407, 2005.
Japanese Article About a utility of the muscle afferent block guide lower botulinum toxin therapy for the II-C1-3 spasmodic torticollis
Kazuhito Tsuruta 1, Tadanobu Kuribayashi 2, Yuki Mizushima 3, Chika Kai 3, Yutaka Nagakura oneself 3
Neurological Therapeutics 22(3): 408-408, 2005.
Japanese Article Examination of the new therapy for II-C1-4 dystonia
Masahiro Horiuchi, Kikuko Shiobara, Yoichi Takahashi
Neurological Therapeutics 22(3): 408-408, 2005.
Japanese Article Trismus as the side effect of the II-C2-1 Botulinum toxin therapy
赫洋美, Miki Osawa male, Makoto Iwata
Neurological Therapeutics 22(3): 409-409, 2005.
Japanese Article Comparison between function prognosis - blepharospasm and hemifacial spasm - with the II-C2-2 Botulinum toxin treatment
Yutaka Naito, Shigeki Kuzuhara
Neurological Therapeutics 22(3): 409-409, 2005.
Japanese Article Bilateral globus pallidus stimulation therapy (GPi-DBs) for the II-C2-3 dystonia tarda
Hideki Shimazu 1, Eiko Murase 1, Naoko Matsui 1, Private temple Hiroyuki 1, Toshinari Nakane 1, Izumi mere sincerity 1, 梶龍兒 1, Kazuhito Matsuzaki 2, 永廣信治 2, 山田和慶 3, Megumi Goto 3
Neurological Therapeutics 22(3): 410-410, 2005.
Japanese Article An effect of the a small amount of L-dopa therapy on II-C2-4 Gille de la Tourette syndrome (GTS) and the factor which gives it to an effect
Kei Hachimori, Atsumi Segawa, Kyoko Hoshino, Kazue Kimura, Yoshiko Nomura, Masaya Segawa
Neurological Therapeutics 22(3): 410-410, 2005.
Japanese Article FK506 therapy in myasthenia gravis who had the II-C3-1 articular rheumatism
Takashi Fukuoka daylight, Ko Sahashi, Masahiko Takahashi, Manabu Iwata, Akira Hoshino, Taro Nakamori, Fujikake Akifumi, Spring Masayuki, Naoki Nakao, Ebi
Neurological Therapeutics 22(3): 411-411, 2005.
Japanese Article Examination of the tacrolimus optimum blood level in the II-C3-2 immunity neurologic disease
Tomoo Hirahara, Taro Yamashita, Hiroyuki Omori, Teruyuki Hirano, Eiichiro Uyama, Makoto Uchino
Neurological Therapeutics 22(3): 411-411, 2005.
Japanese Article Examination of the efficacy of tacrolimus for II-C3-3 myasthenia gravis
South Naoya 1, Naoto Fujiki 1, Shizuka Doi tree 1, Isao Shima two 1, Hidenao Sasaki 2
Neurological Therapeutics 22(3): 412-412, 2005.
Japanese Article Steroid weight loss effect of tacrolimus in myasthenia gravis after the II-C3-4 thymus extirpation
Masahiko Watanabe, Okoshi religion husband, Akira Tamaoka, Shinichi Shoji
Neurological Therapeutics 22(3): 412-412, 2005.
Japanese Article Use experience of the immunoglobulin high dose therapy for II-C4-1 myasthenia gravis
Field volost Hideaki, Yutaka Shiga plus, Takafumi Hasegawa, Yasuto Itoyama
Neurological Therapeutics 22(3): 413-413, 2005.
Japanese Article Treatment of the pregnancy, childbirth, or the puerperium period of II-C4-2 thymoma postoperative patients with myasthenia gravis which presented crisis in early pregnancy
An upper profit very much, 好永順二, Kanzaki Akihiro, Yoshio Shimizu
Neurological Therapeutics 22(3): 413-413, 2005.
Japanese Article Is the thymus extirpation effective for old and middle age myasthenia gravis of the II-C4-3 thymoma non-merger?
Naoki Kawaguchi 1, Yuko Nemoto 1, Satoshi Kuwahara 1, Toshio Fukutake 1, Kodo Hattori 1, Mitsuhiro Osame 2, 有村公良 2
Neurological Therapeutics 22(3): 414-414, 2005.
Japanese Article The myasthenia gravis (MG) patients who repeat symptom relapse with increase of the II-C4-4 peripheral-blood mononuclear cells interleukin-2-producing ability
Yuriko Nagane, The spear swamp New Komeito, Yasuo Terayama
Neurological Therapeutics 22(3): 414-414, 2005.
Japanese Article Measures of multidrug-resistant Pseudomonas aeruginosa urinary tract infection complicated with II-D1-1 neurologic disease
Shigeru Sato 1, Hiroshi Nomura 1, Yasuto Itoyama 2
Neurological Therapeutics 22(3): 415-415, 2005.
Japanese Article One case of nerve Behcet which occurred at II-D1-2 advanced age, and presented recurrent remission
Naoki Izawa 1, Jin Abe period 1, Yoshihiro Tanno 1, Tetsuya Ishihara 1, Soichi Katayama 1, Koichi Hirata 2
Neurological Therapeutics 22(3): 415-415, 2005.
Japanese Article Examination of three relapsing polychondritis in the II-D1-3 this hospital
Akira Taniguchi 1, Kiyomi Oodate 1, Masahiro Miyoshi 1, Shigeki Kuzuhara 2, Chizuko Ota 3, 4
Neurological Therapeutics 22(3): 416-416, 2005.
Japanese Article chlorpromazine administration for the isolated Creutzfbldt-Jakob illness (Sporadic CJD) of the II-D1-4 senile-onset
Takeshi Hayashi 1, Toshiyuki Sakai 1, 伊藤伸朗 2, 小久保康昌 2, Shigeki Kuzuhara 2
Neurological Therapeutics 22(3): 416-416, 2005.
Japanese Article We examine appropriate discharge time and length of stay shortening in patients with II-D2-1 aseptic meningitis
Satoru Oishi Mizuko, Atsuo Chiba, Manabu Sakuta
Neurological Therapeutics 22(3): 417-417, 2005.
Japanese Article One case of MRSA meningitis that measured teicoplanin concentrations out of the cerebrospinal fluid during II-D2-2 treatment
Masahiko Inoue 1, Yoshihiro Wakayama 1, Takahiro Jimi 1, 与芝真彰 2
Neurological Therapeutics 22(3): 417-417, 2005.
Japanese Article Histories of treatment of the II-D2-3 severe form virus-related limbic encephalitis
Ichiro Nakanishi, Hideto Miwa, Tomoyoshi Kondo
Neurological Therapeutics 22(3): 418-418, 2005.
Japanese Article II-D2-4. The interferonα intraspinal injection therapy for chronic enterovirus meningitis encephalomyelitis the merger was X-linked Mu γ-globulin blood disease.
山田郁子, 中村雄作, 八木祐吏, 阪本光, 畠中剛久
Neurological Therapeutics 22(3): 418-418, 2005.
Japanese Article One case of the herpes brainstem encephalitis treated effectively with II-D2-5 steroid-pulse therapy
Tatsuzo Watanabe, Hiroaki Oguro, Shuhei Yamaguchi, Yoshihiro Kobayashi
Neurological Therapeutics 22(3): 419-419, 2005.
Japanese Article Women with 77 years old of the intermittent type carbon monoxide poisoning that continued treatment by hyperbaric oxygen to an index for II-D3-1 magnetic resonance spectroscopy findings
Takeshi Terashima 1, Seiji Takagi 1, Teruo Kimura 2, Shin Ohara elegant 1, Yoko Matsuzawa 1, Keiko Tanaka 1, Masatoyo Nishizawa 1
Neurological Therapeutics 22(3): 419-419, 2005.
Japanese Article 1 case that presented disturbance of consciousness and lethal arrhythmia by the acute poisoning of the II-D3-2 commercial antitussive expectorant
Yasuhiro Ito, 近藤直英, Takeshi Yasuda, Yoshiro Ando
Neurological Therapeutics 22(3): 420-420, 2005.
Japanese Article One case of intermittent type anthracemia that showed significant psychoneurotic improvement by the treatment by hyperbaric oxygen that started from II-D3-3 onset approximately 80 days later
Hishikawa wish 1, 川合圭成 1, Masahiro Iijima 1, Sugiura truth 2, 道勇学 1, Sofue former 1
Neurological Therapeutics 22(3): 420-420, 2005.
Japanese Article It is examination of a utility, the validity in the short term hospital admission nerves intractable disease ward the quality of life improvement questionnaire of II-D4-1 nerves, myopathy inpatients
Katsuhisa Ogata 1, Masafumi Ogawa 1, Mitsuru Kawai 2
Neurological Therapeutics 22(3): 421-421, 2005.
Japanese Article How do the II-D4-2 patients catch treatment guidelines and EBM?
廣西昌也 1, Tomoyoshi Kondo 2
Neurological Therapeutics 22(3): 421-421, 2005.
Japanese Article II-D4-3. The respite care for nerve intractable disease: Short-term hospitalization use to special disease care ward
美原盤1, 永島隆秀1, 五味愼太郎2
Neurological Therapeutics 22(3): 422-422, 2005.
Japanese Article Utility of the music therapy in the II-D4-4 cognitive dysfunction (dementia) patients
Masato Matsuyama, 宮崎眞佐男, Taku Nishida, Yuka Machino
Neurological Therapeutics 22(3): 422-422, 2005.
▲